definiens: shall mean all informatio n and materials, including but not limited to, discoveries, information, Improvements, processes, formulae, data, inventions, know - how and trade secr ets, patentable or otherwise and all biological, chemica l, pharmaceutical, toxicological, preclinical, clin ical, assay control, technical and nontechnical data and inform ation, including the results of test, assays, metho ds, and processes, and manufacturing, regulatory, and any o ther information used or useful for the development, manufacturing and/or regulatory approval of Compoun d or Product, ( including, without limitation, the formulation, delivery or use thereof including synt hesis, preparation, recovery and purification proce sses and techniques ), which ( a ) re late to Compound or Product ; and ( b ) are owned by ANGIOGENE or are in ANGIOGENE ’s po ssession or control and as to which ANGIOGENE has the right to license or sublicense to Third Parties